Cargando…
Impact of Implementing a “FIB‐4 First” Strategy on a Pathway for Patients With NAFLD Referred From Primary Care
Detection of advanced fibrosis in nonalcoholic fatty liver disease (NAFLD) is essential for stratifying patients according to the risk of liver‐related morbidity. Noninvasive methods such as vibration‐controlled transient elastography (VCTE) and Fibrosis‐4 index (FIB‐4) have been recommended to iden...
Autores principales: | Davyduke, Tracy, Tandon, Puneeta, Al‐Karaghouli, Mustafa, Abraldes, Juan G., Ma, Mang M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771169/ https://www.ncbi.nlm.nih.gov/pubmed/31592044 http://dx.doi.org/10.1002/hep4.1411 |
Ejemplares similares
-
Impact of statin treatment on non-invasive tests based predictions of fibrosis in a referral pathway for NAFLD
por: Al-Karaghouli, Mustafa, et al.
Publicado: (2022) -
Patient Views on Advance Care Planning in Cirrhosis: A Qualitative Analysis
por: Carbonneau, Michelle, et al.
Publicado: (2018) -
Carvedilol—NSBB of Choice in All Cirrhotics? Short Title: Carvedilol for Portal Hypertension
por: Tandon, Puneeta, et al.
Publicado: (2015) -
A systematic review on pharmacokinetics, cardiovascular outcomes and safety profiles of statins in cirrhosis
por: Sung, Shuen, et al.
Publicado: (2021) -
Prognostic accuracy of FIB‐4, NAFLD fibrosis score and APRI for NAFLD‐related events: A systematic review
por: Lee, Jenny, et al.
Publicado: (2021)